← Back to Search

Reflective Tools for Chronic Pain

N/A

Waitlist Available

Led By Hannah Smotrich

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Persistent or recurrent pain lasting longer than 3 months

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (t1), approximately 45 days (t4 exit interview)

Awards & highlights

Study Summary

This trial tests a reflective process to help people with chronic pain by empowering them and supporting their resilience.

Who is the study for?

This trial is for individuals who have been experiencing chronic pain for more than three months and can read and write English. It's not suitable for those with a history of bone cancer, current cancer treatment plans, severe psychiatric disorders, recent or ongoing substance abuse, recent disability claims or litigation involvement, participation in other conflicting studies, or uncontrolled depression.Check my eligibility

What is being tested?

The study tests self-guided activities designed to empower people with chronic pain by fostering resilience and thriving. Participants will use reflective tools at home to help manage their condition. The hypothesis is that most will find the intervention easy to understand and effective after orientation.See study design

What are the potential side effects?

Since the interventions are non-medical self-guided activities focusing on reflection and personal empowerment without drugs or devices involved, there are no direct medical side effects associated with this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had pain for more than 3 months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (t1), approximately 45 days (t4 exit interview)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (t1), approximately 45 days (t4 exit interview)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (t1), approximately 45 days (t4 exit interview) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percent of participants engaged in the interventions

Secondary outcome measures

Change in Patient Global Impression of Change (PGIC) at visit approximately 45 days (t4 exit interview)

Change in ability to participate in social roles and activities based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0 between baseline (t1) approximately 45 days (t4 exit interview)

Change in anxiety based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 version 2.0 between baseline (t1) and approximately 45 days (t4 exit interview)

+6 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Reflective process groupExperimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Self-guided at home activities

2023

N/A

~30

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor

1,797 Previous Clinical Trials

6,378,035 Total Patients Enrolled

31 Trials studying Chronic Pain

3,783 Patients Enrolled for Chronic Pain

National Center for Advancing Translational Sciences (NCATS)NIH

321 Previous Clinical Trials

401,726 Total Patients Enrolled

2 Trials studying Chronic Pain

30 Patients Enrolled for Chronic Pain

Hannah SmotrichPrincipal InvestigatorUniversity of Michigan

Media Library

Self-guided at home activities Clinical Trial Eligibility Overview. Trial Name: NCT05847881 — N/A

Chronic Pain Research Study Groups: Reflective process group

Chronic Pain Clinical Trial 2023: Self-guided at home activities Highlights & Side Effects. Trial Name: NCT05847881 — N/A

Self-guided at home activities 2023 Treatment Timeline for Medical Study. Trial Name: NCT05847881 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it still possible to join this medical trial as a participant?

"Clinicaltrials.gov indicates that this research program is recruiting participants as of now, with the initial posting occurring on April 25th 2023 and latest update being May 5th 2023."

Answered by AI

What is the population size of this medical experiment?

"True. According to details posted on clinicaltrials.gov, this medical trial is still recruiting participants and was initially published on April 25th 2023 before being updated most recently on May 5th 2023. The study requires the recruitment of twenty individuals from one centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Toward Thriving: A Set of Reflective Tools to Empower Chronic Pain Patients and Help Them Envision a Personal Path to Thriving.

Hannah Smotrich 2023. "Toward Thriving: A Set of Reflective Tools to Empower Chronic Pain Patients and Help Them Envision a Personal Path to Thriving.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05847881.